Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Discover which credit card offers the highest cash back rewards. Maximize your earnings and get the most from your spending.
28,203 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
In a volatile 2026 market, retirees are choosing stability over constant client chasing. Experts say build income fir...
The memory market has been on a wild ride. After sharp gains earlier this year, Micron and SanDisk pulled back, promp...
HF Sinclair delivered a solid earnings beat, but shares fell sharply after leadership news. This article breaks down ...
Markets swing wildly during downturns, testing nerves and portfolios. Here are three stock market turmoil: crucial st...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
Stocks drift lower in mid-June 2026 as investors reassess AI and chip names. This guide lays out what look when buyin...
SpaceX shocked markets with a rapid price swing after its public debut. This guide breaks down how to evaluate the di...
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
A discreet fund quietly builds a Mattel stake, signaling conviction or a calculated thesis. This article breaks down ...